Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-195"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-11-24"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"it"^^xsd:language2
lpv:document identification number	"en.20101124.15.3-195"2
lpv:hasSubsequent	lp_eu:2010-11-24-Speech-3-1962
lpv:speaker	lp:Sergio Paolo Francesco Silvestris2
lpv:spokenAs	member; EPP (2009-07-14--2012-02-02)3 substitute; BUDG (2010-05-05--2012-01-18)3 substitute; Delegation for relations with Albania, Bosnia and Herzegovina, Serbia, Montenegro and Kosovo (2009-09-16--2014-06-30)3 member; Delegation to the Parliamentary Assembly of the Union for the Mediterranean (2009-09-16--2014-06-30)3 member; AGRI (2010-05-05--2012-01-18)3 unknown; Il Popolo della Libertà (2009-07-14--2013-12-11)3 member; Delegation for relations with the Maghreb countries and the Arab Maghreb Union (2009-09-16--2014-06-30)3
lpv:translated text	"Our vote in favour of this measure is a consequence of the formal distinction that has been made between information on medicinal products and advertising. We support the greater dissemination of information on medicinal products, if this improves patients’ awareness. We do not, and shall never, agree with any measure that clearly or surreptitiously attempts to introduce forms of advertising, turning an ethical medicinal product into a commercial product. The fact that the information on drugs will not be allowed to be published in newspapers or magazines, nor much less broadcast on the radio or television, is therefore appreciated. It is also a good thing that this proposal for a directive clarifies which and how much information can and must be divulged, including scientific information and clearly excluding advertising material. The amendment that introduces certification and monitoring of Internet sites that publish said information further assures us that the information will not constitute advertising. The pharmacy is and must remain a basic healthcare facility, and as such a protected area with regard to the rules of trade and competition. We believe that this rule helps pharmacies carry out their difficult role in pharmacovigilance and education on the correct use of medicinal products."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph